Economist Paul Krugman offered a blunt assessment of Donald Trump’s appeal to Republican voters in an interview with Bloomberg TV host Joe Weisenthal on Monday.
“He’s a belligerent, loudmouth racist with not an ounce of compassion for less fortunate people,” Krugman said. “In other words, he’s exactly the kind of person the Republican base consists of and identifies with. It’s clear that the very things that Upper West Side New Yorkers find detestable about him are exactly what endear him to the Republican base, which is basically people who see in him everything — even the big red face and the yelling — that makes him their kind of guy.”
“So when conservatives say, ‘He’s not really one of us,’ you don’t buy it,” Weisenthal replied.
Krugman argued that the GOP establishment had lost the ability to limit their field of presidential contenders to people who could put a “smoother face” on their platform, for at least part of the primary process.
A similar thing happened in 2012, he added, when several “loudmouthed, angry ludicrous candidates” enjoyed brief success in early polling — much like the kind Trump has been enjoying recently.
“In the end, they nominated Mitt Romney, who on substance was not that different the others,” Krugman recalled. “And probably, the same thing will happen this time around, with Jeb Bush playing that role.”
Watch Krugman’s take on Trump, as aired on Monday, below.
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.